BYL719L-NAMEUCL-TRO-1938acute myocardial infarctioncardiovascular disease
…was abrogated by co-treatment with the PI3Kα-specific inhibitor BYL719, confirming the specificity of 1938 for the PI3Kα pathway. In f…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…was abrogated by co-treatment with the PI3Kα-specific inhibitor BYL719, confirming the specificity of 1938 for the PI3Kα pathway. In f…
… we recently developed the first allosteric activator of PI3Kα, UCL-TRO-1938 (or ‘1938’), and showed that it significantly reduced infarct s…